Financial Daily from THE HINDU group of publications
Wednesday, Jun 01, 2005

News
Features
Stocks
Port Info
Archives
Google

Group Sites

Corporate - Announcements
Marketing - New Products & Services


Win Medicare launches Divigel

Our Bureau

NEW DELHI: Win Medicare Pvt Ltd has announced the launch of Divigel, a treatment for women suffering from menopausal and peri-menopausal symptoms. Divigel is manufactured by Orion Pharma.

Mr Surjit S. Aurora, Vice-President, said: "We have entered into a marketing alliance with Orion Pharma to launch Divigel in India. It is important to realise that women spend one third of their lives in post-menopausal status and hence it is necessary to ensure that women are physically and mentally healthy during these years."

Divigel is available in a gel form; a box of Divigel contains 28 sachets of 1 g each priced at Rs 615.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page


Stories in this Section
Salem Steel Plant to take up Rs 1,136-cr modernisation


BHEL to pay 80 pc final
Apollo Tyres suspends operations
Win Medicare launches Divigel
Jindal Poly Films to tap market to raise Rs 300 cr
ONGC may soon recover dues from 3 other defaulters
`Independent directors should form 1/3 of board'
Irani panel submits report on company law

Bill on new company law in monsoon session
Phasing out polluting vehicles — IndianOil Petronas to gain from Bengal Govt's move
Dabur may re-evaluate Odopic's relevance to product portfolio
Tata Chem to reconsider bid offer for Egyptian Fertiliser
French chem company gets land in pharma city in Vizag
Shasun products in US, Europe
Ranbaxy gets tentative USFDA nod for AIDS drug Lamivudine
`FACT facing liquidity crisis'
NHPC plans to invest Rs 68,000 cr to hike generation capacity — Profits up 10 pc at Rs 684 cr


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line